Vitamin D Supplementation on Cardiovascular Risk Factors

Completed · Not applicable

Conditions studied: Type 2 Diabetes

In brief

The purpose of the present pilot study is to determine the effect of vitamin D supplementation (4000 IU or 6000 IU once daily for 6 months) on reducing heart disease risk and in improving blood glucose control in type 2 Diabetes subjects . The investigators are working with Hispanics and African Americans living in Miami, Florida.

Key facts

Study ID

NCT01412710

Run by

Florida International University

People needed

92

Starts

2011-07-01

Expected to finish

2013-09-01

Last updated by the study team

2017-12-12

Who can join

Age: 30 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Type 2 diabetes
• African American or Hispanic
• able to ambulate on their own
• aged between 30 - 70 years

You may not qualify if…

• Taking Supplemental Vitamin D
• Pregnant or Lactating women
• Receiving insulin therapy
• Not participating in other drug trials
• HIV/ hepatitis/ cancer/ liver disease/ heart failure/ any recent surgery/ mental illness/ epilepsy/ any GI or malabsorption disorders
• Kidney failure or on dialysis

Where it is running

• Human Nutrition Laboratory, Florida International University — Miami, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.